Dashboard
Manage Tickers

SDGR Schrodinger, Inc.

Nasdaq schrodinger.com


$ 20.57 $ -0.45 (-2.14 %)    

Monday, 03-Nov-2025 19:19:45 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 20.55
$ 21.00
$ 20.38 x 1
$ 21.41 x 24
$ 20.31 - $ 21.23
$ 16.60 - $ 28.47
951,089
na
1.51B
$ 1.88
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 02-26-2025 01-01-1970 10-K
4 11-12-2024 09-30-2024 10-Q
5 07-31-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-28-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-11-2021 03-31-2021 10-Q
19 03-04-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-13-2020 03-31-2020 10-Q
23 03-16-2020 12-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
10 Health Care Stocks Whale Activity In To...
11/03/2025 17:35:20

copernic-catalysts-surpasses-final-technical-milestone-for-its-jointly-developed-ammonia-synthesis-catalyst-with-schrodinger
Copernic Catalysts Surpasses Final Technic...
10/30/2025 11:38:52

Copernic Catalysts, Inc. (Copernic) today announced that, in collaboration with Schrödinger, Inc. (Nasdaq: SDGR), the companies...

keybanc-maintains-overweight-on-schrodinger-lowers-price-target-to-28
Keybanc Maintains Overweight on Schrodinge...
10/08/2025 13:16:48

Keybanc analyst Scott Schoenhaus maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers the price target from $30 ...

expert-outlook-schrodinger-through-the-eyes-of-5-analysts
Expert Outlook: Schrodinger Through The Ey...
09/30/2025 14:01:44

goldman-sachs-initiates-coverage-on-schrodinger-with-neutral-rating-announces-price-target-of-19
Goldman Sachs Initiates Coverage On Schrod...
09/30/2025 12:37:50

Goldman Sachs analyst Andrea Newkirk initiates coverage on Schrodinger (NASDAQ:SDGR) with a Neutral rating and announces Pri...

schrdinger-announces-a-separation-and-release-of-claims-agreement-with-dr-geoffrey-porges-as-executive-vice-president-and-cfo
Schrödinger Announces A Separation And Rel...
09/08/2025 20:24:19

-SEC Filing-SEC Filing

what-4-analyst-ratings-have-to-say-about-schrodinger
What 4 Analyst Ratings Have To Say About S...
08/18/2025 21:03:03

morgan-stanley-maintains-equal-weight-on-schrodinger-lowers-price-target-to-19
Morgan Stanley Maintains Equal-Weight on S...
08/18/2025 13:49:45

Morgan Stanley analyst Vikram Malhorta maintains Schrodinger (NASDAQ:SDGR) with a Equal-Weight and lowers the price target f...

this-cisco-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday
This Cisco Analyst Is No Longer Bullish; H...
08/15/2025 14:53:07

citigroup-downgrades-schrodinger-to-neutral-lowers-price-target-to-20
Citigroup Downgrades Schrodinger to Neutra...
08/15/2025 10:54:49

Citigroup analyst David Lebowitz downgrades Schrodinger (NASDAQ:SDGR) from Buy to Neutral and lowers the price target from $...

this-azz-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday
This AZZ Analyst Begins Coverage On A Bull...
08/14/2025 17:11:47

schrdinger-discontinues-the-clinical-development-program-for-sgr-2921-which-was-being-evaluated-in-a-phase-1-dose-escalation-study-for-relapsedrefractory-acute-myeloid-leukemia-or-high-risk-myelodysplastic-syndromes-citing-two-patient-deaths
Schrödinger Discontinues The Clinical Deve...
08/14/2025 11:06:07

barclays-initiates-coverage-on-schrodinger-with-overweight-rating-announces-price-target-of-25
Barclays Initiates Coverage On Schrodinger...
08/14/2025 10:48:58

Barclays analyst Peter Lawson initiates coverage on Schrodinger (NASDAQ:SDGR) with a Overweight rating and announces Price T...

schrodinger-affirms-fy2025-sales-guidance-of-24344m-25746m-vs-25320m-est
Schrodinger Affirms FY2025 Sales Guidance ...
08/06/2025 21:04:35

Schrodinger (NASDAQ:SDGR) affirms FY2025 sales outlook from $243.44 million-$257.46 million to $243.44 million-$257.46 million ...

schrodinger-q2-adj-eps-065-beats-083-estimate-sales-5476m-beat-5203m-estimate
Schrodinger Q2 Adj. EPS $(0.65) Beats $(0....
08/06/2025 20:13:12

Schrodinger (NASDAQ:SDGR) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.83) b...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

ajax-therapeutics-and-schrdinger-expand-research-collaboration-to-include-additional-jak-target
Ajax Therapeutics And Schrödinger Expand R...
07/17/2025 12:18:25

keybanc-maintains-overweight-on-schrodinger-lowers-price-target-to-30
Keybanc Maintains Overweight on Schrodinge...
07/14/2025 12:38:39

Keybanc analyst Aleksey Yefremov maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers the price target from $32 ...

schrdinger-receives-fda-fast-track-designation-for-sgr-1505-in-relapsedrefractory-waldenstrm-macroglobulinemia
Schrödinger Receives FDA Fast Track Design...
06/27/2025 12:12:59

schrdinger-reports-22-response-rate-in-early-trial-for-drug-resistant-b-cell-cancers
Schrödinger Reports 22% Response Rate in E...
06/12/2025 11:09:42

Schrödinger, Inc. (NASDAQ:SDGR) today announced encouraging initial clinical data from its ongoing Phase 1, open-label, dose-es...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION